These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 30940698)
1. Intestinal Epithelial Cells and the Microbiome Undergo Swift Reprogramming at the Inception of Colonic Citrobacter rodentium Infection. Hopkins EGD; Roumeliotis TI; Mullineaux-Sanders C; Choudhary JS; Frankel G mBio; 2019 Apr; 10(2):. PubMed ID: 30940698 [TBL] [Abstract][Full Text] [Related]
2. Citrobacter amalonaticus Inhibits the Growth of Citrobacter rodentium in the Gut Lumen. Mullineaux-Sanders C; Carson D; Hopkins EGD; Glegola-Madejska I; Escobar-Zepeda A; Browne HP; Lawley TD; Frankel G mBio; 2021 Oct; 12(5):e0241021. PubMed ID: 34609899 [TBL] [Abstract][Full Text] [Related]
3. Citrobacter rodentium mouse model of bacterial infection. Crepin VF; Collins JW; Habibzay M; Frankel G Nat Protoc; 2016 Oct; 11(10):1851-76. PubMed ID: 27606775 [TBL] [Abstract][Full Text] [Related]
4. Citrobacter rodentium induces rapid and unique metabolic and inflammatory responses in mice suffering from severe disease. Carson D; Barry R; Hopkins EGD; Roumeliotis TI; García-Weber D; Mullineaux-Sanders C; Elinav E; Arrieumerlou C; Choudhary JS; Frankel G Cell Microbiol; 2020 Jan; 22(1):e13126. PubMed ID: 31610608 [TBL] [Abstract][Full Text] [Related]
5. Epithelial talin-1 protects mice from Latour YL; Allaman MM; Barry DP; Smith TM; Williams KJ; McNamara KM; Jacobse J; Goettel JA; Delgado AG; Piazuelo MB; Zhao S; Gobert AP; Wilson KT Gut Microbes; 2023; 15(1):2192623. PubMed ID: 36951501 [TBL] [Abstract][Full Text] [Related]
6. Overview of the Effect of Citrobacter rodentium Infection on Host Metabolism and the Microbiota. Hopkins EGD; Frankel G Methods Mol Biol; 2021; 2291():399-418. PubMed ID: 33704766 [TBL] [Abstract][Full Text] [Related]
7. Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen. Bergstrom KS; Guttman JA; Rumi M; Ma C; Bouzari S; Khan MA; Gibson DL; Vogl AW; Vallance BA Infect Immun; 2008 Feb; 76(2):796-811. PubMed ID: 17984203 [TBL] [Abstract][Full Text] [Related]
8. Citrobacter rodentium Infection Induces Persistent Molecular Changes and Interferon Gamma-Dependent Major Histocompatibility Complex Class II Expression in the Colonic Epithelium. Mullineaux-Sanders C; Kozik Z; Sanchez-Garrido J; Hopkins EGD; Choudhary JS; Frankel G mBio; 2021 Feb; 13(1):e0323321. PubMed ID: 35100877 [TBL] [Abstract][Full Text] [Related]
9. Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Chen CC; Louie S; Shi HN; Walker WA Pediatr Res; 2005 Dec; 58(6):1185-91. PubMed ID: 16306191 [TBL] [Abstract][Full Text] [Related]
10. Polyethylene glycol diminishes pathological effects of Citrobacter rodentium infection by blocking bacterial attachment to the colonic epithelia. Qi W; Joshi S; Weber CR; Wali RK; Roy HK; Savkovic SD Gut Microbes; 2011 Sep; 2(5):267-73. PubMed ID: 22067938 [TBL] [Abstract][Full Text] [Related]
12. Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). Ma C; Wickham ME; Guttman JA; Deng W; Walker J; Madsen KL; Jacobson K; Vogl WA; Finlay BB; Vallance BA Cell Microbiol; 2006 Oct; 8(10):1669-86. PubMed ID: 16759225 [TBL] [Abstract][Full Text] [Related]
13. TLR9 limits enteric antimicrobial responses and promotes microbiota-based colonisation resistance during Citrobacter rodentium infection. Yang H; Yu HB; Bhinder G; Ryz NR; Lee J; Yang H; Fotovati A; Gibson DL; Turvey SE; Reid GS; Vallance BA Cell Microbiol; 2019 Jul; 21(7):e13026. PubMed ID: 30893495 [TBL] [Abstract][Full Text] [Related]
14. The Citrobacter rodentium type III secretion system effector EspO affects mucosal damage repair and antimicrobial responses. Berger CN; Crepin VF; Roumeliotis TI; Wright JC; Serafini N; Pevsner-Fischer M; Yu L; Elinav E; Di Santo JP; Choudhary JS; Frankel G PLoS Pathog; 2018 Oct; 14(10):e1007406. PubMed ID: 30365535 [TBL] [Abstract][Full Text] [Related]
15. IL-22-dependent responses and their role during Melchior K; Gerner RR; Hossain S; Nuccio S-P; Moreira CG; Raffatellu M Infect Immun; 2024 May; 92(5):e0009924. PubMed ID: 38557196 [TBL] [Abstract][Full Text] [Related]
16. Effects of hypoxic exposure on immune responses of intestinal mucosa to Citrobacter colitis in mice. Ji Q; Zhang Y; Zhou Y; Gamah M; Yuan Z; Liu J; Cao C; Gao X; Zhang H; Ren Y; Zhang W Biomed Pharmacother; 2020 Sep; 129():110477. PubMed ID: 32768962 [TBL] [Abstract][Full Text] [Related]
17. Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma. Simmons CP; Goncalves NS; Ghaem-Maghami M; Bajaj-Elliott M; Clare S; Neves B; Frankel G; Dougan G; MacDonald TT J Immunol; 2002 Feb; 168(4):1804-12. PubMed ID: 11823513 [TBL] [Abstract][Full Text] [Related]
18. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. Bergstrom KS; Kissoon-Singh V; Gibson DL; Ma C; Montero M; Sham HP; Ryz N; Huang T; Velcich A; Finlay BB; Chadee K; Vallance BA PLoS Pathog; 2010 May; 6(5):e1000902. PubMed ID: 20485566 [TBL] [Abstract][Full Text] [Related]
19. Deprivation of dietary fiber in specific-pathogen-free mice promotes susceptibility to the intestinal mucosal pathogen Neumann M; Steimle A; Grant ET; Wolter M; Parrish A; Willieme S; Brenner D; Martens EC; Desai MS Gut Microbes; 2021; 13(1):1966263. PubMed ID: 34530674 [TBL] [Abstract][Full Text] [Related]